AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · IEX Real-Time Price · USD
2.630
-0.300 (-10.24%)
Jul 26, 2024, 4:00 PM EDT - Market closed
AEON Biopharma Market Cap
AEON Biopharma has a market cap or net worth of $102.89 million as of July 26, 2024. Its market cap has increased by 54.03% in one year.
Market Cap
102.89M
Enterprise Value
97.73M
1-Year Change
54.03%
Ranking
Category
Stock Price
$2.63
Market Cap Chart
Since February 9, 2021, AEON Biopharma's market cap has decreased from $259.00M to $102.89M, a decrease of -60.27%. That is a compound annual growth rate of -23.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 26, 2024 | 102.90M | -61.53% |
| Dec 29, 2023 | 267.50M | -22.84% |
| Dec 30, 2022 | 346.70M | 3.49% |
| Dec 31, 2021 | 335.00M | 29.34% |
| Feb 9, 2021 | 259.00M | - |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zentek | 105.28M |
| Sensus Healthcare | 105.24M |
| Sagimet Biosciences | 104.36M |
| Alpha Teknova | 102.47M |
| Aclaris Therapeutics | 99.77M |
| IO Biotech | 99.15M |
| Checkpoint Therapeutics | 98.31M |
| Xtant Medical Holdings | 97.18M |